IRTC saw its Momentum Indicator move above the 0 level on October 19, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 72 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.
The Moving Average Convergence Divergence (MACD) for IRTC just turned positive on October 15, 2026. Looking at past instances where IRTC's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
IRTC moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IRTC crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +3.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRTC advanced for three days, in 255 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The 10-day RSI Indicator for IRTC moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 26 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
IRTC broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IRTC entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IRTC's P/B Ratio (21.866) is slightly higher than the industry average of (4.209). IRTC's P/E Ratio (-293.738) is considerably lower than the industry average of (1.433). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (4.398) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. IRTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
LIVN saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 60 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 69%.
The Moving Average Convergence Divergence (MACD) for LIVN just turned positive on October 09, 2026. Looking at past instances where LIVN's MACD turned positive, the stock continued to rise in 32 of 47 cases over the following month. The odds of a continued upward trend are 68%.
LIVN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LIVN crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIVN advanced for three days, in 206 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 106 of 186 cases where LIVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 59 cases where LIVN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
LIVN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. LIVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.283) is normal, around the industry mean (4.209). P/E Ratio (22.890) is within average values for comparable stocks, (1.433). Projected Growth (PEG Ratio) (0.899) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (2.954) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
IRTC | LIVN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | 100 | |
SMR RATING 1..100 | 93 | 55 | |
PRICE GROWTH RATING 1..100 | 51 | 41 | |
P/E GROWTH RATING 1..100 | 58 | 83 | |
SEASONALITY SCORE 1..100 | 10 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRTC's Valuation (3) in the Medical Specialties industry is significantly better than the same rating for LIVN (76). This means that IRTC’s stock grew significantly faster than LIVN’s over the last 12 months.
IRTC's Profit vs Risk Rating (62) in the Medical Specialties industry is somewhat better than the same rating for LIVN (100). This means that IRTC’s stock grew somewhat faster than LIVN’s over the last 12 months.
LIVN's SMR Rating (55) in the Medical Specialties industry is somewhat better than the same rating for IRTC (93). This means that LIVN’s stock grew somewhat faster than IRTC’s over the last 12 months.
LIVN's Price Growth Rating (41) in the Medical Specialties industry is in the same range as IRTC (51). This means that LIVN’s stock grew similarly to IRTC’s over the last 12 months.
IRTC's P/E Growth Rating (58) in the Medical Specialties industry is in the same range as LIVN (83). This means that IRTC’s stock grew similarly to LIVN’s over the last 12 months.
| IRTC | LIVN | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 81% | N/A |
| Stochastic ODDS (%) | 4 days ago 77% | 4 days ago 75% |
| Momentum ODDS (%) | 4 days ago 83% | 4 days ago 69% |
| MACD ODDS (%) | 4 days ago 79% | 4 days ago 68% |
| TrendWeek ODDS (%) | 4 days ago 78% | 4 days ago 70% |
| TrendMonth ODDS (%) | 4 days ago 80% | 4 days ago 66% |
| Advances ODDS (%) | 5 days ago 79% | 5 days ago 68% |
| Declines ODDS (%) | 26 days ago 80% | 7 days ago 74% |
| BollingerBands ODDS (%) | 4 days ago 82% | 4 days ago 73% |
| Aroon ODDS (%) | 4 days ago 81% | 4 days ago 57% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRTC’s FA Score shows that 1 FA rating(s) are green while LIVN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRTC’s TA Score shows that 5 TA indicator(s) are bullish while LIVN’s TA Score has 6 bullish TA indicator(s).
IRTC (@Medical/Nursing Services) experienced а +1.73% price change this week, while LIVN (@Medical/Nursing Services) price change was -2.39% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.62%. For the same industry, the average monthly price growth was -6.73%, and the average quarterly price growth was -7.68%.
IRTC is expected to report earnings on Nov 05, 2026.
LIVN is expected to report earnings on Nov 04, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, IRTC has been loosely correlated with STE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRTC jumps, then STE could also see price increases.
| Ticker / NAME | Correlation To IRTC | 1D Price Change % | ||
|---|---|---|---|---|
| IRTC | 100% | -3.47% | ||
| STE - IRTC | 45% Loosely correlated | -2.16% | ||
| GEHC - IRTC | 41% Loosely correlated | +0.20% | ||
| INGN - IRTC | 39% Loosely correlated | -5.51% | ||
| LIVN - IRTC | 39% Loosely correlated | -2.81% | ||
| SYK - IRTC | 39% Loosely correlated | -6.38% | ||
More | ||||
A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with CRL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To LIVN | 1D Price Change % | ||
|---|---|---|---|---|
| LIVN | 100% | -2.81% | ||
| CRL - LIVN | 48% Loosely correlated | -4.44% | ||
| NVST - LIVN | 42% Loosely correlated | -4.47% | ||
| A - LIVN | 41% Loosely correlated | -3.47% | ||
| MTD - LIVN | 39% Loosely correlated | -2.55% | ||
| MMSI - LIVN | 39% Loosely correlated | -7.66% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LDDR | 75.34 | 0.22 | +0.29% |
| Stone Ridge Trust Stone Ridge 2035 Term Income ETF | |||
| RVNU | 23.76 | 0.01 | +0.06% |
| Xtrackers Municipal Infrastructure Revenue Bond Active ETF (RVNU) | |||
| VCLN | 25.38 | N/A | N/A |
| Virtus Duff & Phelps Clean Energy ETF (VCLN) | |||
| DUBS | 42.41 | -0.84 | -1.94% |
| Aptus Large Cap Enhanced Yield ETF (DUBS) | |||
| JMOM | 79.52 | -2.65 | -3.23% |
| JPMorgan U.S. Momentum Factor ETF (JMOM) | |||